follow

Leading the Fight to treat and cure
Tay-Sachs, Canavan, Sandhoff, GM1 and related diseases

NTSAD In The News

Boston Business Journal - 'This disease takes away everything': One family's story of Tay-Sachs
Published: February 27, 2015. The first clue that something might be wrong with Cameron was, oddly enough, a diagnosis of Tay-Sachs disease in her cousin.

Boston Business Journal - With the help of patient groups, biotechs hone in on rare diseases
Published: February 26, 2015. Shire Pharmaceuticals made its name developing drugs for osteoporosis, Alzheimer's disease and attention deficit hyperactivity disorder, but its future lies firmly in treatments for rare diseases.

Back Issues

Visit our library of eNews for copies of past newsletters, research updates, topics of the week and more

News Feeds

Browse a collection of recent new articles collected around the Internet. View News Feeds

Sign up for News

 

Enter your email to receive NTSAD's Topic of the Week or quarterly news.


 

Enter your email to receive NTSAD's Topic of the Week or quarterly news.


 

Enter your email to receive NTSAD's Topic of the Week or quarterly news.


Login